Related references
Note: Only part of the references are listed.Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia
Yasunori Nakagawa et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
Marin H. Kollef et al.
CRITICAL CARE (2012)
Epileptogenic Potential of Carbapenem Agents: Mechanism of Action, Seizure Rates, and Clinical Considerations
April D. Miller et al.
PHARMACOTHERAPY (2011)
A Multicenter, Randomized Controlled Clinical Study on Biapenem and Imipenem/Cilastatin Injection in the Treatment of Respiratory and Urinary Tract Infections
Bei Jia et al.
CHEMOTHERAPY (2010)
Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis
K. G. Naber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Overview of Seizure-Inducing Potential of Doripenem
George G. Zhanel et al.
DRUG SAFETY (2009)
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: A phase III, prospective, multicenter, randomized, double-blind, noninferiority study
Christopher Lucasti et al.
CLINICAL THERAPEUTICS (2008)
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia:: a randomized, open-label, multicenter study
Alvaro Rea-Neto et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Seizures in adults with bacterial meningitis
E. Zoons et al.
NEUROLOGY (2008)
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Michael J. Bradburn et al.
STATISTICS IN MEDICINE (2007)
Safety profile of meropenem - An updated review of over 6000 patients treated with meropenem
Peter Linden
DRUG SAFETY (2007)
Practice guidelines for the management of bacterial meningitis
AR Tunkel et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treatment of febrile neutropenic patients with cancer who require hospitalization - A prospective randomized study comparing imipenem and cefepime
II Raad et al.
CANCER (2003)
Carbapenems in the treatment of severe community acquired pneumonia in hospitalized elderly patients: A comparative study against standard therapy
G Romanelli et al.
JOURNAL OF CHEMOTHERAPY (2002)
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia
N Vetter et al.
CLINICAL THERAPEUTICS (2002)
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults
G Ortiz-Ruiz et al.
CLINICAL INFECTIOUS DISEASES (2002)
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients
DJ Winston et al.
CLINICAL INFECTIOUS DISEASES (2001)
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia
FA Lerma
JOURNAL OF CHEMOTHERAPY (2001)
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial
R Feld et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit
C Verwaest
CLINICAL MICROBIOLOGY AND INFECTION (2000)
Share Paper
